Earnings Call · Q2 FY2024·2024-08-01

Q2 24EPS +68.42%·Rev n/aQ1 24EPS +7.23%·Rev n/aQ4 23EPS +92.77%·Rev n/aQ3 23EPS +4.49%·Rev n/a⚠ consensus missing

IONIS PHARMACEUTICALS INC IONS

Wade Walke — Senior Vice President of Investor Relations

Brett Monia — Chief Executive Officer

Richard Geary — Executive (likely in R&D or Medical Affairs)

Kyle Jenne — Executive (likely in Commercial or Medical Affairs)

Elizabeth Hougen — Executive (likely CFO or Finance)

+3.8%1d on move date+5.2% vs SPY3d−5.0%5d−5.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IONS calls or request research access.

More IONS calls Browse calls Request research access